Demographic and Clinical Patterns of Rheumatoid Arthritis in an Emirati Cohort from United Arab Emirates

Abstract EN

This retrospective cohort study aimed to assess the demographic and clinical characteristics of rheumatoid arthritis (RA) in Emirati patients attending Cleveland Clinic Abu Dhabi, a large tertiary center in the Middle East.

In this study, 414 Emirati patients with RA were evaluated over a 3-year period from April 2015 to April 2018.

All patients fulfilled the 2010 RA ACR/EULAR criteria and were assessed for demographic and clinical characteristics.

The estimated RA prevalence rate in our population cohort was 2.72%.

Females showed predominance (80%) with a higher body mass index (31.4 ± 6.61, P=0.0001) compared to males (28.8 ± 6.03, P=0.0001).

The most frequent comorbidity observed was dyslipidemia (43.5%) followed by hypertension (37.9%), diabetes mellitus (34.5%), and gastroesophageal reflux disease (33.1%).

Xerophthalmia was the most frequent extra-articular manifestation.

Rheumatoid factor and anti-citrullinated peptide were detected in 63.3% and 41.5% patients, respectively, while both were present in 33.3% of patients.

Methotrexate, adalimumab, and rituximab were the most frequently prescribed disease modifying agents.

In this study, we describe disease features that are unique to United Arab Emirates (UAE) patients and demonstrate that RA has a significant disease burden.

Our findings highlight the need for a RA national registry to improve the quality of care of these patients in UAE.